EU "soft-justice" for Boehringer Ingelheim but are patent thickets legal?
This article was originally published in Scrip
Executive Summary
The European Commission has dropped its investigation into allegations made by the Spanish firm, Almirall, that Boehringer Ingelheim had misused the patent system to exclude potential competition in the chronic obstructive pulmonary disease space. The two companies have reached an agreement, the commission announced yesterday.